Johnson & Johnson (JNJ) Inventory (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Inventory came in at $15.1 billion in Q2 2026, up 12.91% year-over-year from $13.4 billion in Q2 2025, and up 3.85% quarter-over-quarter from $14.6 billion in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Inventory (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Inventory across 18 years of filings, most recently posting $15.1 billion for Q2 2026.
- In Q2 2026, Inventory rose 12.91% year-over-year to $15.1 billion; the TTM figure through Jun 2026 stood at $15.1 billion (up 12.91% YoY), while the FY2025 annual figure was $14.2 billion, up 14.04% from the prior year.
- Inventory came in at $15.1 billion for Q2 2026 at Johnson & Johnson, up from $14.6 billion in the prior quarter.
- In the past five years, Inventory ranged from a high of $15.1 billion in Q2 2026 to a low of $10.3 billion in Q1 2023.
- Average Inventory over 5 years is $12.4 billion, with a median of $12.4 billion recorded in 2024.
- Year-over-year, Inventory gained 16.55% in 2023 and fell 11.13% in 2024.
- Over 5 years, Inventory stood at $11.7 billion in 2022, then decreased by 4.23% to $11.2 billion in 2023, then grew by 11.3% to $12.4 billion in 2024, then rose by 14.04% to $14.2 billion in 2025, then gained by 6.72% to $15.1 billion in 2026.
- Per Business Quant data, the three most recent Inventory figures were $15.1 billion in Q2 2026, $14.6 billion in Q1 2026, and $14.2 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 15.14 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 5.13 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 6.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 6.22 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 9.95 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 12.93 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 112.54 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 193.80 Mn |
| 10 | Neurocrine Biosciences | 15.82 Bn | 15.43 Bn | 935.80 Mn | 104.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 15.14 Bn |
| Mar 29, 2026 | 14.58 Bn |
| Dec 28, 2025 | 14.19 Bn |
| Sep 28, 2025 | 14.15 Bn |
| Jun 29, 2025 | 13.41 Bn |
| Mar 30, 2025 | 12.66 Bn |
| Dec 29, 2024 | 12.44 Bn |
| Sep 29, 2024 | 12.60 Bn |
| Jun 30, 2024 | 12.17 Bn |
| Mar 31, 2024 | 11.38 Bn |
| Dec 31, 2023 | 11.18 Bn |
| Oct 1, 2023 | 11.20 Bn |
| Jul 2, 2023 | 12.89 Bn |
| Apr 2, 2023 | 12.81 Bn |
| Jan 1, 2023 | 10.27 Bn |
| Oct 2, 2022 | 11.68 Bn |
| Jul 3, 2022 | 11.44 Bn |
| Apr 3, 2022 | 10.99 Bn |
| Jan 2, 2022 | 10.39 Bn |
| Oct 3, 2021 | 10.39 Bn |